Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1051336

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Autoimmune Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the public purse of treating and managing (a) rheumatoid arthritis, (b) inflammatory bowel disease and (c) psoriasis.
tabling member constituency	St Ives
tabling member printed	Derek Thomas
uin	214623
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>No specific estimate has been made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:23:09 answering member 4067 label Biography information for Steve Brine
tabling member	4532 label Biography information for Derek Thomas

1051338

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Autoimmune Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) NHS England have made a comparative assessment of the effectiveness of treating immune-mediated inflammatory conditions (i) holistically and (ii) according to the physical location of the inflammation; and if he will make a statement.
tabling member constituency	St Ives
tabling member printed	Derek Thomas
uin	214625
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>No specific assessment has been made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:21:20 answering member 4067 label Biography information for Steve Brine
tabling member	4532 label Biography information for Derek Thomas

1051440

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kawasaki Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to raise awareness of the signs and symptoms of Kawasaki disease among NHS health professionals.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	214517
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>Guidance is available from the National Institute for Health and Care Excellence (NICE) on the assessment and initial management of fever in children under five, and this guidance includes recommendations on recognising the symptoms of Kawasaki disease.</p><p> </p><p>NICE’s clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence; the guidelines are not mandatory, although health and care commissioners are expected to take them fully into account.</p><p> </p><p>Information about the symptoms, causes, diagnosis, treatment and complications of Kawasaki disease is also available on the National Health Service website.</p><p> </p><p>Furthermore, learning information and resources for clinicians about Kawasaki disease is available from Societi, The UK Kawasaki Disease Foundation. Societi engages with a range of NHS stakeholders to raise awareness of Kawasaki disease, and has a number of senior clinicians on its Scientific Advisory Board who work in leading NHS institutions and who have expertise in relevant clinical areas such as vasculitis and paediatric cardiology.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:22:23 answering member 4067 label Biography information for Steve Brine
tabling member	1400 label Biography information for Kevin Brennan

1051483

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what is the cost to the NHS is of each FreeStyle Libre flash glucose monitoring device.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	214472
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>The cost of 1 FreeStyle Libre sensor, 1 sensor applicator, and 1 wipe is £35 as listed in the February 2019 Drug Tariff.</p><p> </p><p>Net Ingredient Cost is the basic price of a drug as stated in Part II Clause 8 of the Drug Tariff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:32:42 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz

1051485

registered interest
date	30/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	214473
answer	answer is ministerial correction date of answer 07/02/2019 answer text <p>On 14 November 2018, it was announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, in line with National Health Service clinical guidelines.</p><p> </p><p>The Department has not made any representations to Abbott since.</p><p> </p><p>Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This should include consideration of access to diabetes technologies such as FreeStyle Libre.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/02/2019 15:18:43 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz